Livforsakringsbolaget Skandia’s Core Laboratories CLB Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-819	Closed	-$81K	–	706
2017 Q3	$81K	Hold	819	–	–	0.01%	679
2017 Q2	$83K	Hold	819	–	–	0.01%	671
2017 Q1	$95K	Sell	819 -3,900	-83%	-$453K	0.01%	663
2016 Q4	$566	Sell	4,719 -481	-9%	-$53.3K	0.03%	539
2016 Q3	$932K	Buy	5,200 +481	+10%	+$55.4K	0.05%	470
2016 Q2	$585K	Hold	4,719	–	–	0.03%	573
2016 Q1	$530K	Hold	4,719	–	–	0.02%	601
2015 Q4	$513K	Hold	4,719	–	–	0.02%	603
2015 Q3	$471K	Hold	4,719	–	–	0.02%	600
2015 Q2	$538K	Hold	4,719	–	–	0.03%	590
2015 Q1	$493K	Sell	4,719 -1,900	-29%	-$202K	0.02%	609
2014 Q4	$797K	Hold	6,619	–	–	0.04%	565
2014 Q3	$969K	Hold	6,619	–	–	0.04%	520
2014 Q2	$1.11M	Hold	6,619	–	–	0.04%	492
2014 Q1	$1.31M	Buy	+6,619	New	+$1.25M	0.05%	431

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Livforsakringsbolaget Skandia's CLB Position: Q4 2017 in Review

Livforsakringsbolaget Skandia sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 819 shares — an estimated $81K sold.

Livforsakringsbolaget Skandia first reported a position in CLB in Q1 2014 and held it in 15 quarters. The position peaked at $1.31M in Q1 2014. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

Livforsakringsbolaget Skandia reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
Livforsakringsbolaget Skandia sold 819 Core Laboratories shares in Q4 2017, an estimated $81K.
Livforsakringsbolaget Skandia first reported a position in Core Laboratories in Q1 2014 and held it in 15 quarters.
Livforsakringsbolaget Skandia's Core Laboratories position peaked at $1.31M in Q1 2014.
356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2017, filed 18 Jan 2018.